prospective randomized controlled trail
Conditions
Interventions
1micg/kg dexmedetomedine slowly intravenously and 0.5 mg/kg atracuoruim and intubated with an endotracheal tube of suitable size Patients will receive Hartman'
s solution in 5% glucose solution at the ratio 3:1 as by Segar formula. Patients will be ventilated by pressure controlled mode, inspiratory pressure = 20 cmH2O, and rate will be adjusted to maintain
s solution in 5% glucose solution at the ratio 3:1 as by Segar formula. Patients will be ventilated by pressure controlled m
Sponsors
Mansoura university , Faculty of medicine, Department of anesthesia and surgical intensive care,Devision of Neuro anesthesia
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: . It will include patients 2 years old and younger of both gender; after obtaining informed signed consent from patients guardians; who will be schedule for neurosurgical procedures. patients must be older than 44 weeks post gestation
Exclusion criteria
Exclusion criteria: younger than 44 weeks post gestational, with known cardiovascular diseases, renal diseases, hepatic diseases, pulmonary diseases, systemic or local infection will be excluded from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the perioperative Face, leg agitation, cry and consoability( FLACC) scores relating to pain and agitation in infants | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in hemodynamic both intra and post operatively will supplement our primary outcomes. | — |
Countries
Africa
Contacts
Public ContactFatma MF Lahloub
Mansoura university , Faculty of medicine, Department of anesthesia and surgical intensive care Neuro anesthesia
Outcome results
None listed